Navigation Links
Mayo Clinic Clarifies Diagnosis and Treatment for Rare, Serious Blood Vessel Disease of Brain and Spinal Cord
Date:10/18/2007

ROCHESTER, Minn., Oct. 18 /PRNewswire-USNewswire/ -- Mayo Clinic has clarified the methods of diagnosis and optimal management of a rare and little-understood blood vessel disease of the brain and spinal cord that often leads to stroke or death. Primary central nervous system vasculitis (PCNSV) can best be identified through a combination of diagnostic techniques consisting of angiography (imaging the cerebral arteries), brain biopsy and other laboratory studies.

This disease is often suspected based on a combination of symptoms, along with the initial results of brain imaging with CT or MRI. The Mayo study clarifies the usefulness of the evaluation techniques and suggests that a combined diagnostic approach is needed. Primary central nervous system vasculitis is difficult to diagnose because it is not a single disease, but a variable syndrome that appears to consist of several distinct subsets of different diseases that can mimic other less-serious conditions, thus eluding treatment. Frequent symptoms are headache, altered cognition, or stroke, and visual symptoms. Recognizing the symptoms and understanding the role of evaluation techniques, may lead to earlier identification and treatment of patients.

This Mayo Clinic analysis of 101 patients seen with primary central nervous system vasculitis over 21 years represents one of the largest reported groups of patients with this disorder. The Mayo Clinic research report on improved understanding of PCNSV appears in the current edition of Annals of Neurology (http://www3.interscience.wiley.com/cgi-bin/jissue/78504407).

Significance of the Mayo Clinic Research

Primary central nervous system vasculitis has two traits that make it difficult, yet important, to study:

-- It is rare and poorly understood. Few medical centers see enough patients with confirmed diagnoses to collect enough data to anal
'/>"/>

SOURCE Mayo Clinic
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... -- Authentidate Holding Corp. (Nasdaq: ADAT ... Information Exchange and workflow management services, today ... ("HCC"), a home health agency, and Alliance ... supplier, have selected Authentidate,s Inscrybe® Healthcare web-based ... the completion of patient care orders. Both ...
(Date:12/14/2009)... Accuray Incorporated (Nasdaq: ARAY ), ... announced today that the first CyberKnife® Robotic Radiosurgery ... University Hospital of Liege. ,, The University ... of the largest hospitals in Euregio, a cross-country ... a full range of cancer treatments, University Hospital ...
(Date:12/14/2009)... The U.S. Food and ... Extended Release Injectable Suspension for the treatment of ... LLY ) announced today. ZYPREXA RELPREVV, ... olanzapine for up to four weeks. ,, Different ... formulations of antipsychotics allow for stable concentrations of ...
Breaking Medicine Technology:Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 2Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 3Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 4First CyberKnife in Belgium to be Installed at Leading University Hospital 2First CyberKnife in Belgium to be Installed at Leading University Hospital 3FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 2FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 3FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 4FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 5FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 6FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 7FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 8Gear bans can help save reefs 8893 1Gear bans can help save reefs 8893 2Gear bans can help save reefs 8893 3Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 1Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 2Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 3Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 4Elekta Provides VMAT and Radiosurgery Solutions for New Jersey Health System 49349 1Elekta Provides VMAT and Radiosurgery Solutions for New Jersey Health System 49349 2Elekta Provides VMAT and Radiosurgery Solutions for New Jersey Health System 49349 3
(Date:12/14/2009)... (PHILADELPHIA) Researchers from Thomas Jefferson University are one step ... , Led by Matthias J. Schnell, Ph.D., director ... a rabies virusbased vaccine administered to monkeys protected against ... data were published in the journal Vaccine . ... expressing HIV and SIV antigens protective against a chimeric ...
(Date:12/14/2009)... dislocations, ,sculpting, procedure may be long-term solution, researchers ... Patients who frequently experience shoulder dislocations can benefit ... using bone and cartilage from cadavers, new research ... December issue of the American Journal of ... be an alternative to methods that stabilize or ...
(Date:12/14/2009)... MPE, offers protective garments online to military and government personnel ... ... Ind. (PRWEB) December 14, 2009 -- Miller,s Precision Enterprises, Inc. ... announces its recent approval as a vendor on the Department ... EMALL vendor, MPE can provide military, government and Civil Agency ...
(Date:12/14/2009)... are expressing their views on the key factors ... of them indicating that television, video games, movies ... are also stated as highly instrumental among this ... Stop Violence. ,, (Photo: http://www.newscom.com/cgi-bin/prnh/20091214/PH24980 ... 12 years, analyzed the contents of 10,000 essays ...
(Date:12/14/2009)... unrecognized, experts say , , MONDAY, Dec. 14 (HealthDay News) ... the United States who have mental problems, including attention-deficit ... , However, "you could look at it the other ... senior investigator at the U.S. National Institute of Mental ... Dec. 14 in Pediatrics . , Depression and ...
Breaking Medicine News(10 mins):Health News:MPE Inc., a Leading Supplier of Recycled Protective Garments, Becomes Approved Vendor on DOD EMALL 2Health News:Middle Schoolers Identify Violent Content in Youth-Targeted Entertainment as a Strong Influence in Causing Youth Violence 2Health News:Middle Schoolers Identify Violent Content in Youth-Targeted Entertainment as a Strong Influence in Causing Youth Violence 3Health News:Middle Schoolers Identify Violent Content in Youth-Targeted Entertainment as a Strong Influence in Causing Youth Violence 4Health News:Half of U.S. Kids With Mental Issues Are Getting Help 2Health News:Half of U.S. Kids With Mental Issues Are Getting Help 3
... wealth of healthcare and medical device experience to board ... of ... developer,of the first and only flexible CO2 laser scalpel enabling new ... been,elected to the company,s board of directors. Suennen, co-founder and,managing member ...
... Despite Higher Use - - Cancer Drug Spending ... - Drug Trend ... May 15 Diabetes,treatments are now the leading driver of prescription ... of,reigning in the top position, as generic drugs cut the cost ...
... With hurdles like identifying,and retaining top talent, building ... meeting business objectives while managing,four generations in the ... a,critical business issue respectfully sits at the corporate ... talent management program that will,impact the bottom line., ...
... (Nasdaq:,EVVV) today announced that Pat Spangler, senior vice president ... 2008 FBR Capital Markets,Spring Investor Conference on Thursday, May ... Time and 11:20 a.m. Pacific Time). The 2008 FBR,Capital ... Grand Hyatt,Hotel, located at 109 East 42nd Street, New ...
... /Xinhua-PRNewswire-FirstCall/ -- Mindray,Medical International Limited (NYSE: ... marketer of medical devices worldwide, today announced ... patient monitoring,device business pursuant to the terms ... 11, 2008., The combined business benefits ...
... -- By targeting and disabling a protein frequently found in ... more vulnerable to chemotherapy, according to a new study by ... a compound that can weaken the tumor by targeting a ... chemotherapy was applied to the tumor in this weakened state ...
Other Medicine News:Health News:Lisa M. Suennen Joins OmniGuide(R) Board of Directors 2Health News:Diabetes Drugs Emerge as Top Force in Drug Spending Growth 2Health News:Diabetes Drugs Emerge as Top Force in Drug Spending Growth 3Health News:Diabetes Drugs Emerge as Top Force in Drug Spending Growth 4Health News:Diabetes Drugs Emerge as Top Force in Drug Spending Growth 5Health News:Discover Talent Management Best Practices June 4-6 -- Registration Ends Friday 2Health News:Mindray Medical Completes Acquisition of Datascope's Patient Monitoring Business 2Health News:Mindray Medical Completes Acquisition of Datascope's Patient Monitoring Business 3Health News:Targeted therapy plus chemotherapy may pack 1-2 punch against melanoma 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: